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Submitted Oct 2, 2013; accepted Jan 9, 2014.DISCUSSIONDr Joseph L. Mills (Tucson, Ariz). The Oregon group has re-
ported today that an endovascular-ﬁrst approach has no adverse
impact on ability to perform or outcomes after open bypass if
open bypass is subsequently required. This would be comforting,
if it were true. However, these results contrast markedly with larger
published series and raise the question of whether the results you
have heard today from a single institution are generalizable. The
BASIL authors observed that patients who underwent bypass sur-
gery after an initial failed angioplasty experienced signiﬁcantly
worse amputation-free survival than did those who underwent
bypass ﬁrst as the initial therapy (P ¼ .006), suggesting that there
is a real potential adverse impact of the endovascular-ﬁrst approach
for all patients with severe limb ischemia. Others, including the
VSGNE, have made similar observations. Nolan et al reviewed
1153 patients who underwent lower extremity bypass from 2003
to 2008. Patients who had undergone a prior ipsilateral failed
percutaneous intervention had signiﬁcantly higher rates of graft
occlusion and major limb amputation at 1 year by multivariate
analysis. I will grant that vein grafts work better than prosthetic
for CLI.
Why the disparity? Almost 30% of endovascular-ﬁrst patients
reported in the Oregon series had iliac PTA, a procedure that is
quite unlikely to adversely impact LE bypass and in fact might
even be beneﬁcial (or have been planned in a staged hybrid
approach to limb salvage). What percentage of your patients had
endo by your own group (as opposed to endo performed else-
where prior to referral)?
Dr Vincent J. Santo. Twenty-one of 61 patients had their
endovascular intervention at OHSU prior to bypass. Forty patients
had their endovascular intervention prior to referral to OHSU.
DrMills.What was mean time from EVT to bypass? Delays in
achieving adequate perfusion after inadequate revascularization in
patients with wounds can lead to larger wounds and often super-
imposed infection. We know from Eurodiale and others report
that infection triples amputation risk in patients with PAD and
that persistence or nonhealing of wounds increases risk of
infection.
Dr Santo. We do not have information on the time lapse be-
tween the endovascular intervention and subsequent bypass
because for those patients treated outside the OHSU system,
this information was either imprecise or entirely unavailable.
Dr Mills. Did you speciﬁcally examine patients who had un-
dergone prior SFA stents? Ihnat et al reported that SFA stent oc-
clusion worsened SVS runoff score, leading to a net loss of onerunoff vessel per failed stent. Could you determine whether a
previous endovascular procedure impacted target site for bypass
(eg, converted fem-pop to fem-tib target)?
Dr Santo. We did not analyze the subset of patients who
received SFA stenting, as this only included eight patients and
we felt any statistical analysis would be underpowered. We also
did not attempt to analyze any changes in “best distal target” again
because the majority of patients were treated prior to arriving in
the OHSU system and we did not have baseline angiographic data.
Dr Mills. Finally, there were relatively few tibial interventions.
Were there any pedal interventions? There are reports from Italy of
adverse impact on pedal bypass after failed tibial/pedal interven-
tions. In the U.S., Vogel et al reported in 2011, using a Medicare
database of 13,258 interventions for CLI, that tibioperoneal an-
gioplasty was associated with frequent in-hospital complications,
an overall 30-day amputation rate of 23.8% for all procedures
and indications, and a 30-day rehospitalization rate of almost
30%.1 The relative aggressiveness of EVT in the Paciﬁc Northwest
seems remarkably low.
Dr Santo. There were no endovascular pedal interventions
performed in this patient population.
Dr Mills. Do you have any data on patients who underwent
amputation after failed EVT without bypass? It seems to me you
would need that data and that such patients would be systemati-
cally excluded from your series.
Dr Santo. Unfortunately, we do not have that data available
yet. We know that roughly 700 interventional and 700 diagnostic
angiograms were performed at OHSU during the same study
period, but the details of these interventions have not yet been
extracted. This is the subject of a future study and we agree, it
will be very interesting to know the outcome of these interventions
to better understand the “denominator” in this patient population.
Dr Mills. I am willing to accept that judicious EVT is unlikely
to impact ability to perform bypass. However, I also am conﬁdent
that quite a bit of injudicious infrainguinal endovascular therapy is
being widely performed, so I am not sure the results you have re-
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